Peter J. Goadsby

Research interests

Publications

• Migraine

  Nature Reviews Disease Primers · 2022 · 10.1038/s41572-021-00328-4

• Galcanezumab in chronic migraine

  Neurology · 2018 · 10.1212/wnl.0000000000006640

• Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine

  JAMA · 2018 · 10.1001/jama.2018.4853

• Pathophysiology of Migraine: A Disorder of Sensory Processing

  Physiological Reviews · 2017 · https://doi.org/10.1152/physrev.00034.2015

• A Controlled Trial of Erenumab for Episodic Migraine

  New England Journal of Medicine · 2017 · 10.1056/nejmoa1705848

• Fremanezumab for the Preventive Treatment of Chronic Migraine

  New England Journal of Medicine · 2017 · 10.1056/nejmoa1709038

• Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS)

  Cephalalgia · 2010 · 10.1177/0333102410381145

• EFNS guideline on the drug treatment of migraine – revised report of an EFNS task force

  European Journal of Neurology · 2009 · 10.1111/j.1468-1331.2009.02748.x

• New Appendix Criteria Open for a Broader Concept of Chronic Migraine

  Cephalalgia · 2006 · https://doi.org/10.1111/j.1468-2982.2006.01172.x

• The International Classification of Headache Disorders, 2nd Edition (ICHD-II)—-Revision of Criteria for 8.2 Medication-Overuse Headache

  Cephalalgia · 2005 · https://doi.org/10.1111/j.1468-2982.2005.00878.x

• A Report on the Journal 2004

  Cephalalgia · 2004 · https://doi.org/10.1111/j.1468-2982.2004.00711.x

• Calcitonin Gene–Related Peptide Receptor Antagonist BIBN 4096 BS for the Acute Treatment of Migraine

  New England Journal of Medicine · 2004 · https://doi.org/10.1056/nejmoa030505

• The International Classification of Headache Disorders: 2nd edition

  The Lancet Neurology · 2003 · 10.1016/s1474-4422(03)00590-8

• Premonitory symptoms in migraine

  Neurology · 2003 · 10.1212/01.wnl.0000052998.58526.a9

• Migraine — Current Understanding and Treatment

  New England Journal of Medicine · 2002 · 10.1056/nejmra010917

• Triptans (Serotonin, 5-HT 1B/1D Agonists) in Migraine: Detailed Results and Methods of A Meta-Analysis of 53 Trials

  Cephalalgia · 2002 · 10.1046/j.1468-2982.2002.00404.x

• Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials

  The Lancet · 2001 · 10.1016/s0140-6736(01)06711-3

• Guidelines for Controlled Trials of Drugs in Migraine: Second Edition

  Cephalalgia · 2000 · 10.1046/j.1468-2982.2000.00117.x

• Correlation between structural and functional changes in brain in an idiopathic headache syndrome

  Nature Medicine · 1999 · 10.1038/10561

• The Trigeminovascular System in Humans: Pathophysiologic Implications for Primary Headache Syndromes of the Neural Influences on the Cerebral Circulation

  Journal of Cerebral Blood Flow & Metabolism · 1999 · 10.1097/00004647-199902000-00001

• Hypothalamic activation in cluster headache attacks

  The Lancet · 1998 · 10.1016/s0140-6736(98)02470-2

• A review of paroxysmal hemicranias, SUNCT syndrome and other short- lasting headaches with autonomic feature, including new cases

  Brain · 1997 · 10.1093/brain/120.1.193

• Human in vivo evidence for trigeminovascular activation in cluster headache Neuropeptide changes and effects of acute attacks therapies

  Brain · 1994 · 10.1093/brain/117.3.427

• The trigeminovascular system and migraine: Studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats

  Annals of Neurology · 1993 · 10.1002/ana.410330109

• Vasoactive peptide release in the extracerebral circulation of humans during migraine headache

  Annals of Neurology · 1990 · 10.1002/ana.410280213

• Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system

  Annals of Neurology · 1988 · 10.1002/ana.410230214

Current projects

No projects listed.